Repligen Corporation
RGEN Healthcare Medical Instruments & Supplies
Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.
- Revenue
- +10.9%
- EPS
- −351.9%
- Free cash flow
- −11.5%
- Total debt
- +3.28%
Quarter to September 2026, against a year earlier
Follow RGEN
Alert me
Repligen Corporation (RGEN) Book value per share
Repligen Corporation's book value per share at the end of fiscal 2025 was 37.5×, up 6.20% from 35.3× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 37.0×. Over the past ten years it has ranged from 3.7× (fiscal 2015) to 37.5× (fiscal 2025) — the current reading is the highest in ten years. Repligen Corporation ranks 12th of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 37.5× | 6.20% |
| FY2024 | 35.3× | 0.01% |
| FY2023 | 35.3× | 2.35% |
| FY2022 | 34.5× | 8.30% |
| FY2021 | 31.8× | 9.33% |
| FY2020 | 29.1× | 32.73% |
| FY2019 | 21.9× | 55.86% |
| FY2018 | 14.1× | (9.09%) |
| FY2017 | 15.5× | 207.79% |
| FY2016 | 5.0× | 34.66% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 37.0× | (1.21%) |
| Jun 2026 | 37.4× | 0.20% |
| Mar 2026 | 37.4× | (0.24%) |
| Dec 2025 | 37.5× | 1.16% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| TFX Teleflex Incorporated compare | 66.7× |
| ALGN Align Technology, Inc. compare | 60.6× |
| COO The Cooper Companies, Inc. compare | 43.2× |
| ATR AptarGroup, Inc. compare | 41.5× |
| RGEN Repligen Corporation | 37.0× |
| SOLV Solventum Corporation compare | 28.1× |
| BLCO Bausch + Lomb Corporation compare | 18.2× |
| BAX Baxter International Inc. compare | 12.5× |
| AVTR Avantor, Inc. compare | 8.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on RGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement